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INTRODUCTION
Silk offers a unique suite of structural and functional features to the field of
craniofacial bone repair. No other biomaterial offers this combination of impressive
and controllable mechanical and morphological properties such as biocompatibility,
slow biodegradability, absence of bioburden concerns and options for chemical
decoration due to the diversity of its surface-amino acid side chain chemistries (1).
A comparison of mechanical properties of common silks (silkworm and spider
dragline) to several types of biomaterial fibers and tissues commonly used today
(Table 1) (1) suggests that silks provide a remarkable combination of strength and
toughness. Distinguishing features of silks are high strength and excellent
elasticity. Silks also display resistance to failure in compression that distinguishes
them from other high performance fibers such as Kevlar.
From a clinical perspective, silks are already widely used as suture
materials and are being actively explored for other biomedical applications such as
ligament repair. With an improved understanding of structure-function
relationships, this window of applications for biomedical repairs should continue to
expand. Aside from existing natural source of silk (B. mori silkworm; silk from
sericulture), future options with the development of genetically engineered silk
variants, would expand the set of silk protein structures available for use in vivo.
Examples of potential applications include scaffolds for bone repair, artificial
tendons or muscles, strong sutures and membranes for wound healing. Controllable
structure and morphology, superior mechanical properties, ability to mineralize,
biocompatibility and slow biodegradability of silk will have an important impact in
repairs related to bone defects in dentistry.
Background:
Silk and the tri-peptide arginine-glycine-aspartic acid (RGD)-decorated silk
have been shown to be anabolic for bone formation (2). The RGD sequence is
found in many of the extracellular matrix (ECM) proteins and serves as a binding
site for integrins (transmembrane receptors) present on the plasma membrane of the
osteoblasts. Integrin binding with RGD initiates a cascade of events that leads to
the generation of intracellular signaling pathways responsible for cell adhesion,
motility, shape, proliferation, prevention of apoptosis, and differemiation.
Extracellular Matrix (ECM) Proteins and RGD
The ECM is a part of the connective tissue and has a complex structure
surrounding and supporting cells that are found within mammalian tissues. The
ECM is composed of 3 major classes of biomolecules"
1. Structural proteins- Collagen and Elastin
2. Specialized proteins- Fibronectin, Laminin, Vitronectin etc.
3. Proteoglycans- These are composed of a protein core to which
are attached long chains of repeating disaccharide units termed glycosaminoglycans
(GAGs) forming extremely complex high molecular weight componems of the
ECM.
Osteoblasts bind to the ECM proteins in the bone matrix through integrins
that are present on the surface of osteoblasts. These ECM proteins include
fibronectin, collagen, vitronectin, and osteopontin. Integrins are present in the
plasma membrane of all mammalian cells. Integrin receptor binding and clustering
culminate in the formation of focal adhesion sites where integrins connect the
cytoskeleton and the ECM. Activation of these focal adhesion sites leads to a
signaling cascade, which involves MAP kinase (ERK 1 and 2), its translocation to
the nucleus and the activation of specific genes. This integrin-mediated signaling
pathway affects proliferation and differentiation of osteoblasts.
The process of bone formation starts with derivation of osteoblasts from the
newly organized mesenchyme. As osteoblasts differentiate, they synthesize and
secrete the ECM proteins. During the process of bone formation, proteins are
expressed in a temporal sequence. Major ECM proteins secreted by osteoblasts
includefibronectin, type I collagen, bone sialoprotein, osteopontin and osteocalcin.
A study has shown thatfibronectin is the earliest bone matrix protein expressed in
the process of bone formation (44, 45, 46). Fibronectin contains at least 6 tightly
folded domains each with a high affinity for a different substrate such as heparan
sulfate, collagen, fibrin and cell-surface receptors. Its cell surface receptor-binding
domain contains the tri-peptide amino acid sequence RGD. RGD of fibronectin and
other ECM proteins serve as a ligand for integrins. Data from fibronectin-null
mutant mice embryos show defects in organization of mesoderm and somites
suggesting its importance in migration, adhesion, differentiation, and proliferation
of mesodermal tissue (50). Type I collagen is the most abundant protein in the bone
matrix making up more than 90% of the organic matrix. It is the major component
of osteoid and bone, and is responsible for structural stabilization. Type I collagen
mRNA levels have been shown to increase at the onset of mineralization (46). Bone
sialoprotein is found at the mineralization front (52). It is believed to initiate
mineralization (53, 54) as its levels are reported highest during early bone
formation (46). It is deposited in the osteoid during mineralization and may be
important in nucleating hydroxyapatite. Osteoclasts also bind to bone sialoprotein
suing the ctv[33 integrin receptor. Osteopontin is also found at the mineralization
front and is thought to control mineralization by inhibiting crystallization (55). It is
expressed at a later stage in bone development and may be more important in
remodeling bone. Osteocalcin, a marker of fully differentiated osteoblasts, is
produced by mature osteoblasts during the process of mineralization. Its appearance
is thought to be a signal for bone turnover (56) and differentiation of osteoclasts
(57, 58).
Integrins
Integrins are a large family of heterodimeric transmembrane glycoproteins,
which are the principle receptors for ECM proteins, including collagen,
fibronectin, and laminin. (4). Integrins consist of two transmembrane glycoprotein
subunits, a- and ]3-chains, which are non-covalently bound. The length of the a-
chain is 1008-1152 amino acids, with a cytoplasmic region of 22-32 amino acids,
and a transmembranous part of 20-29 amino acids. The length of the [3-chain is
approximately 770 amino acids, with a cytoplasmic region of 20-50 amino acids,
and an intramembranous part of 26-29 amino acids. The extracellular domains of
and [3-subunits interact with each other, creating a functional heterodimer. Both
subunits contain disulfide bridges, protecting them from proteolysis. Integrins
interact with ECM through the extracellular domain at the ct-subunits (5), with
components of the cytoskeleton and signaling molecules through the intracellular
domain of the [3-subunit. Through these interactions, integrins can regulate many
cellular functions, such as cell adhesion, motility, cell shape, proliferation,
apoptosis, and differentiation (6).
Many combinations of a- and [3-subunits are possible, and each combination
has the capacity to bind one or more ligands (see Table 2). There are 18 a- and 8 13-
subunits. The a-subunit determines the specificity of binding to a particular ligand.
There is also an overlap in specificity with many integrins capable of binding to
more than one protein whereas, many proteins can act as ligands for more than one
integrin. The same integrin molecule in different cell types can have different
ligand binding activities as well, since additional cell type specific factors can
interact with integrins to modulate their binding activity (5). Integrin recognition
sites in many protein ligands consist of short linear sequences that contain an acidic
residue. Additional discontinuous regions of the protein may provide secondary
binding sites (4). One integrin subfamily has been shown to utilize RGD sequence
(Arg-Gly-Asp) to recognize and bind ligands (5). The bone matrix contains many
glycoproteins that have this integrin-binding sequence, such as type I collagen,
fibronectin, vitronectin, thrombospondin and bone sialoprotein (7).
The integrin expression on osteoblasts has already been described in various
studies (8, 9, 10). Human bone cells are capable of expressing a wide variety of
integrins and have been shown to express integrin subunits ctl, a2, a3, a4, a5, a6,
aV, 131,133, and 135 (6), but the pattern of integrin expression varied with the stage
of bone development (9). Differences between studies on integrin expression can
also be the result of cell source, or in vivo versus in vitro characterization. There are
also technical reasons for differences, including the detection technique, method for
fixation and permeabilization, antibody specificity, and immunostaining conditions.
The 13 integrins are the predominant adhesion receptor subfamily utilized
by osteoblasts and osteoblast-like cells and are found in the bone cell receptors for
collagen, fibronectin, laminin and vitronectin (7, 8, 9, 10, 11). Investigators have
identified the integrin, fibronectin receptor, I5 as well as other integrins such as
I31, C81 and (v3 in fetal rat calvarial tissue and cultured osteoblasts at all stages
of differentiation (12). Blocking of the fibronectin receptor by addition of integrin
specific RGD-peptide inhibited mineralization, disrupted osteoblast organization
and mineralized matrix, decreased the osteoclast number in a mineralizing organ
culture system and decreased calcification (13). Inhibition of the (Z5 function with
monoclonal antibodies inhibited osteoblast differentiation (14). Another study
showed that osteoblasts interact with the central cell-binding domain of
endogenously produced fibronectin containing the RGD sequence during early
stages of differentiation (12, 15). These interactions regulated bone nodule
morphogenesis and the expression of mRNA for genes associated with osteoblast
differentiation such as alkaline phosphatase and osteocalcin. These studies suggest
that fibronectin may play an important role in bone cell proliferation and early
stages of differentiation, mediating the maturational pathway of bone cells.
Integrins play an important role in cell anchorage, migration, proliferation,
differentiation and apoptosis (programmed cell death). Imegrins can mediate a
large number of different cellular responses to the ECM depending on cell type, the
integrin receptors expressed by the cell, and the composition of the surrounding
ECM. They are also mechanotransducers of force across the plasma membrane.
The c- and [3-subunit cytoplasmic domains do not have any intrinsic enzymatic
activity, but couple with cytoplasmic proteins that nucleate the formation of large
protein complexes containing both cytoskeletal and catalytic signaling proteins
(16). The assembly of integrins, ECM proteins and intracellular protein complexes
forms focal adhesion sites.
Integrins function as transmembrane linkers mediating the interactions
between the cytoskeleton and the extracellular matrix. By influencing the
cytoskeleton, integrins stabilize cell adhesion and regulate the shape, morphology,
orientation and the movement of cells. The a-cytoplasmic domain contains highly
divergent amino acid sequences while the [3-cytoplasmic domain shows partial
sequence conservation. The [3-cytoplasmic (imernal) domain plays a role in
intracellular signaling whereas, the or- domain (external) regulates the specificity of
the ligand-dependent interactions (16). The 13-subunit connects to the cytoskeleton
of actin filaments through proteins such as talin and ct-actinin, and other
intracellular attachment proteins like vinculin, paxillin and tensin in the focal
adhesion sites. Talin and ct-actinin bind to the integrin cytoplasmic domain in vitro
(5, 16). These assemblies of structural proteins may serve as a framework for the
association of signaling proteins that regulate signal transduction pathways leading
to integrin-induced changes in cell function and cell behavior.
Role oflntegrins in Intracellular Signaling
lntegrins activate intracellular signaling cascades leading to changes in gene
activity. Many of the signal transduction pathways identified previously for growth
factors and cytokines are also activated by integrins. Signaling through both growth
factor receptors and integrins seems to be necessary for optimal cellular responses
such as cell adhesion, proliferation and migration (16). In addition, growth factor
receptors, such as for platelet-derived growth factors and insulin-like growth factor
I, interact with integrins and this interaction is required for growth factor signaling.
The cytoplasmic tails of the integrins bind to signaling molecules, such as one or
more kinases, which then initiate signaling cascades after integrin ligation and
aggregation (17). Protein phosphorylation within focal adhesion sites is one of the
earliest events found in response to integrin stimulation. Tyrosine phosphorylation
has been shown to be a common response to integrin activation in many cell types
(16).
Focal Adhesion Kinase (FAK)" Focal adhesion kinase (FAK or pp125FA:),
located in focal adhesion sites, is one of the major substrates for integrin-induced
tyrosine phosphorylation (18) and induces intracellular signaling. FAK
phosphorylation is important in regulating the formation of new focal adhesions.
However, FAK activation may not be required for the maintenance of focal
adhesions (19). Cellular adhesion to fibronectin and other ECM proteins initiates
integrin clustering resulting in FAK tyrosine phosphorylation and FAK activation.
In fibroblasts, cell adhesion requires phosphorylation and activation of FAK. FAK
activation is reduced in suspended cells (20). When suspended cells are replated on
ECM substrates, FAK is rapidly phosphorylated and shows high levels of kinase
activity.
In fibroblasts and endothelial cells, the auto-phosphorylation of FAK has
been shown to be followed by further tyrosine phosphorylation and recruitment of
other proteins including src to the focal adhesion sites. Intermediate steps involve
the enzymatic activation of proteins by phosphorylation, which ultimately leads to
the stimulation ofMAP kinases.
Mitogen Activated Protein Kinases (MAPK): Integrins (16, 22, 23, 24, 25,
26) and growth factors (21, 22) activate the MAPK signal transduction pathway.
The same pattern of MAPK signaling is used by different signaling pathways that
involve distinct MAPK isoforms (22, 27). Extracellular Regulated Kinase 1 and 2
(ERK1/2) are two 44/42 kDa isoforms of MAPK. It is documented that the ERK
1/2 subfamily is activated by hormones, growth factors and integrins (28). ERK 1/2
have been shown to be phosphorylated in response to the adherence of human skin
fibroblasts to fibronectin or by cross-linking of 131 integrins with antibody (29).
This suggests that integrins are able to activate MAPK (ERK1/2). Phosphorylated
MAP kinase translocates to the nucleus and is able to bind and regulate
transcription factors (16, 26). The nuclear target proteins of MAP kinases include
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fos and jun (members of the AP-1 transcription factor), which allows MAPK to
control gene expression (22, 30).
The Activator Protein 1 (AP-1) Transcription Factor: AP-1 transcription
factor modulates the expression of genes involved in proliferation, differentiation
and neoplastic transformation (30). It is characterized by its ability to alter gene
expression in response to growth factors, cytokines, tumor promoters,
carcinogenesis and increased expression of various oncogenes such as src and ras
(31).
The AP-1 complex is a multiprotein complex composed of the products of
the fos and jun gene families. Fos and jun are nuclear phosphoproteins which
combine to form hetero- or homo-dimer complexes. While jun proteins can form
homo-dimers and hetero-dimers with the fos proteins, fos proteins cannot form
homo-dimers (31). Dimer formation is necessary to bind to the AP-1 recognition
site on the DNA, which stimulates the transcription of genes that contain AP-1
consensus sequences in their promoter regions. Regulation of AP-1 activity in
response to extracellular signals is determined by the levels of transcription of the
fos and jun genes as well as by posttranslational modification (31). The AP-1
complex initiates early transcriptional events which lead to an increase in DNA
synthesis and cell proliferation or it can affect other cellular processes such as
differentiation. AP-1 sites are known to be present in the promoters of many bone
specific genes, such as type I collagen (32), alkaline phosphatase (33), osteocalcin
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(34, 35) and osteopontin (36). Fos has been found to have a critical role in
regulating the development and activities of bone and cartilage cells (37). It can act
both as a transforming oncogene or as cell type specific regulator of differentiation.
Over expression of fos in transgenic mice causes transformation of cells in the
chondrogenic and osteogenic lineages leading, in cooperation with jun, to the
development of chondrosarcomas and osteosarcomas. Fos knockout mice lack
osteoclasts and develop osteopetrosis (37). In vivo expression of c-fos has been
shown to be associated with regions of fetal bone having the highest growth
potential (37, 38). High levels of c-fos, c-jun and junB mRNA during the
proliferative period of osteoblast development has been found (38). These findings
suggest a fundamental role of AP-1 in cell proliferation.
Objectives
Rationale:
Previous work in our laboratory demonstrated that silk-based biomaterials
and RGD-decorated silk were osteogenic by increasing differentiation of
osteoblasts, and stimulating mineralization (2). Additionally, an in vivo study has
shown bone formation in intramuscular implants of silk films seeded with rat
mesenchymal stem cells (MSCs) (3). However, it was not known whether silk and
silk-RGD stimulated bone formation through the activation of integrins and the
MAP kinase signaling pathway.
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Goals:
Our goal was to study integrin expression, proliferation and mineralization
in primary human osteoblasts grown on tissue culture plastic, purified silk films,
purified silk films covalently decorated with the tripeptide RGD and control
tripeptide RAD.
Hypothesis:
Our hypothesis was that decoration of silk films with RGD would enhance
proliferation and mineralization by up-regulating specific integrin subunits in
human osteoblasts.
MATERIAL AND METHODS
Cell culture
Human bone fragments, which are normally discarded after surgery, were
obtained from healthy patients undergoing foot surgery and immediately minced.
The use of this tissue was approved by the Institutional Review Board (IRB) at The
University of Connecticut Health Center. The human osteoblasts (HOBs), used in
our experiments, were obtained from these fragments by culturing them at 37C
and 5% CO2 in DMEM/F12 Ham (Sigma, St. Louis, MO) with 15% fetal bovine
serum (FBS) and 100 units/ml penicillin G and 100 gg/ml of streptomycin sulfate
(Beresford, 1984 #243).
When the tissue culture dishes were almost confluent, the HOBs were
collected by trpysinization and plated at 10,000 cells/cm2 in six-well Costar dishes
(Corning Costar Corp., Cambridge, MA) in DMEM/F12 Ham with 15% fetal
bovine serum (FBS) and 100 units/ml penicillin G and 100 gg/ml of streptomycin
sulfate (Beresford, 1984 #243). The plating sequence (six wells/plate) is shown in
Table 3.
Preparation of Silk Substrates
Silk films were prepared according to Sophia et al., (1). Briefly, cocoons from B.
mori silkworms were boiled for 1 hour in an aqueous solution of 0.02M Na2CO3
and 0.3% (w/v) Ivory soap solution, and then rinsed thoroughly with water to
extract the glue-like sericin proteins. The extracted silk was then dissolved in 9M
LiBr solution overnight at 37C giving a 10% (w/v) solution. This solution was
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dialyzed in water using a Slide-a-Lyzer dialysis cassette (Pierce, MWCO 2000),
lyophilized, and the regenerated silk fibroin dissolved in hexafluoro-2-propanol
(HFIP, Aldrich) to give a 2-3% (w/v) silk fibroin solution. Films were formed by
covering the bottom of the 6-well plates (Costar) with 140 tl of the aqueous (after
dialysis) solution under sterile conditions. The films were air dried for 4-5 hours.
Once the films were dried, they were contacted with a 90/10 (v/v) methanol/water
solution for 10 minutes to induce a conformational change in the silk to prevent
resolubilization in the cell culture media. The films were then dried overnight
before use. In general, films cast from water solutions dried with non-uniform
thickness and tended to crack after the methanol treatment, whereas the HFIP-cast
films had uniform thickness and surfaces and remained so after the methanol
treatment. Therefore, only the ttFIP-cast films were used for cell culture studies.
Covalent coupling ofpeptides to silkfibroinfilms. Silk films were modified
by covalent coupling of RGD and RAD peptides. Briefly, after hydration of silk
films in PBS (pH 6.5) for 1 hour, exposed carboxyl groups of aspartic acid and
glutamic acid amino acids were activated by reaction with an appropriate volmne of
0.5 mg/mL 1-ethyl-3-(dimethylaminopropyl) carbodiimide hydrochloride (EDC)
and 0.7 mg/mL N-hydroxysuccinimide (NHS) solution (Pierce) in phosphate-
buffered saline (PBS) for 15 minutes at room temperature. After activation, silk
films were rinsed extensively to remove excess EDC/NHS and were reacted with 1
mL of either 0.01, 0.05, or 0.1 mg/mL glycine-arginine-glycine-aspartic acid-serine
(GRGDS) peptide (Sigma, St. Louis, MO) or the negative control peptide glycine-
arginine-alanine-aspartic acid-serine (GRADS; Sigma) in PBS for 2 hours at room
15
temperature. To complete the reaction, matrices or films were rinsed extensively in
distilled water and air dried.
Proliferation
During 72 hours of culture, [3H] thymidine (5 tCi/ml) was added to the
cells for the last 4 hours. Cell layers were then extracted twice for 5 minutes with
10% trichloroacetic acid (TCA) and lysed in 0.5 N NaOH for 10 minutes. Liquid
scintillation counting was performed to measure radioactivity in the lysates
(Packard Instrument Co., Downers Grove, IL).
Mineralization
At 7 days of plating, culture medium was changed to aMEM + 15% FBS +
1% Penicillin/Streptomycin (mineralization medium). In addition to the change in
medium, osteoblasts were fed with 50 lag/ml ascorbic acid every other day to
promote mineralization. Day 1 for this group was day 8 of plating. On day 35 of
culture, cells were extracted twice for 30 minutes with 5% TCA. Calcium content
in the cell extract was measured colorimetrically using a calcium kit (Sigma, St.
Louis, MO).
Integrin Expression
Western blots were utilized to probe for integrin expression. Protein
extraction was accomplished by using RIPA cell lysis buffer (50 mM tris-HC1 pH
7.4 + 150mM NaC1 + mM EDTA + protease inhibitor cocktail + 1% sodium
deoxycholate + 0.1% SDS + 0.004% sodium azide). Cell lysate from each time
point and for each substrate was transferred to an eppendorf tube. Each sample was
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spun at 10,000 G for 30 min. BCA protein assay (Pierce, 23225) was performed to
determine the concentration of samples. Samples were stored at -20 C. A sample
of 50 lag of protein was concentrated to 15ul using a lyophylizer. An equal volume
(15 gl) of sample buffer was added to each sample. The final samples were heated
at 95C for 5 min.
Criterion 7.5% acrylamide gels (Bio-rad, 345-0043) were used to separate
the proteins. Pre-stained (Bio-rad, 161-0372) protein standards were added to the
first well, and 30ul of final samples were added to the remaining wells.
Electrophoresis was performed at 200V for 45 min. The gel was equilibrated in
tank buffer for 5 min. Proteins from the gel were transferred to an Immobilon paper
using a blotter tank (Bio-rad, 170-4071) at 100V for lhr.
Protein detection was accomplished by chemiluminescence. The blot
(Immobilon) paper was blocked for lhr. in blocking buffer (5% non-fat milk in
Tween-20 Tris buffered saline (TTBS)) at room temperature. It was incubated at
4C overnight with primary antibodies, one at a time (monoclonal mouse anti-
human antibody for cl, a2, a5, aV, 131 or 133 (Santa Cruz BioTechnologies, Santa
Cruz, CA), 1" 100 concentration in 5% non-fat milk dissolved in Tris-buffered
saline (TBS)). The blot was rinsed with wash buffer [Ix TBS (20mM tris, 150mM
NaC1, pH 7.5), 0.05% Tween-20 (add 0.5 ml Tween-20) (Sigma, P-9416) into 1L
TBS solution]. It was then incubated for 1 hour at room temperature in secondary
antibody [goat anti-rabbit IgG HRP (Pierce, 31430) 1" 10,000 in 5% milk in
TTBS].
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The detection of bands involved the use of a mixture of luminol/enhancer
and peroxide buffer (Bio-rad, 170-5040). Blot was incubated in the substrate mix
for 5 min. X-ray films were exposed to the blot using various exposure times and
developed.
Densitometric and Statistical Analyses
The densitometry of bands in the autoradiographs and chemiluminescence
films was scanned and quantitated by Kodak 1D Image Analysis Software
(Eastman Kodak Company, Rochester, NY). The data are representative of two or
more individual experiments. Statistical analysis was performed by a two-way
analysis of variance using Microsoft(R) Excel(R) (Student-Neuman-Keuls; p< 0.05)
RESULTS
Proliferation
Proliferation of osteoblasts on tissue culture Plastic, Silk, Silk-RGD and
silk-RAD was measured at 72 hours. A graph of the data for proliferation is shown
in Figure 1.
No significant difference was found in proliferation between Plastic and
Silk-RAD groups (p-value 0.355). There was a 2.8 fold increase in [3H]-thymidine
incorporation for Silk compared with the Plastic group but this was not significant
(p-value=0.331). However Silk-RGD group had a 5.8 fold increase in [3H]-
thymidine incorporation that was significant at a p-value of 0.006. Osteoblast
proliferation was also 22 fold higher on Silk-RGD compared to Silk-RAD (p-
value=0.002).
Mineralization
Mineralization, determined by measuring calcium content of the matrix on
all four substrates, was measured after 5 weeks of culture. A graph of
mineralization data is shown in Figure 2.
A significant increase in calcium deposition was seen on Silk compared to
Plastic substrates (p-value=0.04). Significant stimulation of mineralization was
observed for Silk-RGD vs. Plastic and Silk-RAD vs. Plastic substrates with p-
values of <0.05. There was no significant difference in calcium deposition on Silk-
RGD compared to Silk-RAD group (p-value=0.62).
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Integrin Expression
Integrins are important cell surface receptors responsible for attachment of
osteoblasts to ECM proteins. In this study, or l, a2, a5, aV, ]31 and ]33 integrins were
studied for their role in osteoblast function when grown on four different substrates
Plastic, Silk, Silk-RGD and Silk-RAD.
Expression of each of these six integrins was studied at 0 time, 24-hour and
7-day time points by Western blot (Figure 3). Twenty-four hour integrin expression
was compared to 0 time (Figure 4) and 7-day integrin expression was compared to
24-hour by densitometric scans of the Western blots (Figure 5).
Between 0 and 24 hours, osteoblasts on Plastic decreased the 0tl and a2
expression 0.6 and 0.4 fold (Figure 4). Whereas, 131 and 133 expression increased
3.2 and 2.2 fold. No significant change was observed for or5 and aV. On Silk,
expression decreased 0.7 fold. However, 0t5 expression increased 2.2 fold. No
significant changes were found for a2, aV, [31 and 133 on silk. On Silk-RGD group,
a2 expression decreased 0.5 fold while a5 and 131 expression increased 2.2 and 1.9
fold. No change was seen for al, aV or 133 expression on Silk-RGD. Between 0 and
24 hour in the Silk-RAD group, there was a decreased expression of a l, a2 and aV
by 0.5, 0.5 and 0.7 fold. Whereas, an increased expression of 2.8 and 1.5 fold was
observed for a5 and 131 respectively with no significant change in [33.
Between 24 hours and 7 days, osteoblasts on Plastic showed decreased
expression of a l and otV by 0.4 and 0.5 fold (Figure 5). Whereas, increased
expression of 2.6, 6.0, 2.2, and 1.8 fold was seen for a2, a5, [31 and [33 respectively.
On Silk, al and aV expression decreased 0.7 and 0.5 fold while a2, a5, 131 and 133
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expression increased 14.7, 2.3, 4.2 and 2.2 fold respectively. Silk-RGD group
showed decreased otl expression by 0.4 fold. Whereas, t2, a5, tV, 131 and 133
showed increased expression of 2.1, 2.7, 1.3, 1.9, and 1.7 fold respectively.
Between 24 hours and 7-day Silk-RAD groups, al expression decreased 0.6 fold
while a2, a5, aV, 131 and [33 showed increased expression of 2.8, 1.6, 3.0, 2.8 and
2.5 fold respectively.
DISCUSSION
In vivo, human osteoblasts use integrins to attach to the extracellular matrix
(ECM) proteins. Osteoblasts are able to attach to the ECM proteins at the
bone/implant interface and perhaps to the implant material itself via integrins (39,
40). Specifically, integrins recognize and bind to extracellular matrix proteins such
as collagen, fibronectin, laminin, vitronectin etc. In this study, integrins or l, or2, t5,
aV, [31 and 33 that are well documented to be expressed by human osteoblasts (6,
10), were studied for their interactions with novel silk-based biomaterials and
control materials. Since integrins initiate intracellular signaling pathways that affect
cell proliferation and differentiation we evaluated osteoblast proliferation,
mineralization (calcium deposition) and integrin expression.
Osteoblast adhesion to and proliferation on an implant material are the first
vital steps in determining biocompatibility of the substrate. When an implant
material is placed in a tissue defect (in vivo) or in culture medium (in vitro),
proteins will adsorb to its surface. This protein layer will subsequently mediate the
interaction of the implant material with the cells arriving from the surrounding
tissue. Integrins are the adhesion molecules involved in the process of cellular
adhesion. They can also pass information from the ECM to the cell and from the
cell to the ECM (6).
Cell adhesion can be divided into two phases: The attachment phase and the
adhesion phase. Cellular attachment takes place rapidly with short-term events,
such as physicochemical linkages between cell and material involving ionic forces,
van der Waals forces, etc. (41). The adhesion phase occurs in the longer term and
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involves various biological molecules such as extracellular matrix proteins, cell
membrane proteins, and cytoskeleton proteins. These molecules interact together to
induce signal transduction regulating transcription factors, other proteins and gene
expression (41). Integrins are the primary family of cell membrane proteins that
mediate adhesion of cells to substrates.
The expression of integrins in osteoblasts has been demonstrated in vivo and
in vitro. In human bone sections, osteoblasts expressed tl and ct5 sub-units
although a subpopulation of osteoblastic cells expressed a2 and a7 (9). When
primary human osteoblasts adhered to fibronectin, type I collagen and laminin
coated polystyrene dishes in the presence of serum, [33 and a7 integrins were
found in focal contacts. The a4 and 1 subunits were also expressed by primary
human osteoblasts on these substrates. The a2, a6 and a7 integrins were expressed
on control dishes, a2, a3 and a7 on collagen coated dishes and a6 and a7 on
laminin-coated dishes. The [3 subunit was expressed on all surfaces except on
laminin-coated dishes (42). Adhesion to fibronectin-, collagen- and laminin- coated
dishes is inhibited by antibodies to the 131 integrin subunit, however, the antibody to
a5 affects adhesion only to fibronectin (43). An understanding of the integrin
subunits involved in osteoblast adhesion provides essential information for
biomaterial improvement and notably for identification of the proteins, which may
be useful to adsorb on materials before implantation.
Bone is formed with the sequential deposition ofECM proteins. Fibronectin
has been shown to be produced first, by pre-osteoblasts undergoing proliferation in
prenatal mice calvariae that have not begun to mineralize (46). As pre-osteoblasts
23
develop, type I collagen is expressed. From this time onwards, collagen expression
increases gradually, while fibronectin drops precipitously. Type I collagen is the
major ECM protein, comprising 90% of the matrix, and is critical for
mineralization. Increased type I collagen expression has been correlated with an
increase in calcium deposition/mineralization (46). In our study, decreased
expression at 24 hours of both a l and ct2 (collagen integrins) substantiates this
finding as little mineralization is occurring at this time. By 7 days, there is a 2 15
fold increase in a2 expression and a 2- 4 fold increase in [31 expression on all four
substrates. This data suggest that collagen expression is gradually increasing with
the increase in expression of collagen integrins a l and a2. Our 5-week
mineralization (calcium deposition) data shows that most mineralization occurs on
Silk-RGD substrate. It can be postulated that osteoblasts are attaching, proliferating
and mineralizing on Silk-RGD substrates more than on Plastic and Silk substrates.
In case of Silk-RGD this could be explained as increased recognition of RGD as a
ligand by the fibronectin (a5) and collagen (al and a2) integrins of the osteoblasts.
Successful adhesion of osteoblast to the implant material leads to
proliferation. It has been demonstrated that cellular proliferation in osteoblasts is
triggered by the activation of integrins with fibronectin and collagen.. Both type I
collagen and fibronectin support early proliferation in the absence of exogenous
growth factors. Substratum-supported cell growth decreased with protein kinase
inhibitors, indicating that osteoblast integrins signal through kinase-mediated
pathways (44). It has been shown that fibronectin may be critical in the early stage
of bone formation owing to its ability to stimulate osteoblast progenitor
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proliferation and by the induction of c-fos and c-jun. In contrast, type I collagen
affects these parameters less than fibronectin. In our study, human osteoblasts
showed significantly high proliferation on Silk-RGD substrate. Silk substrate
showed lesser proliferation and was followed by the Plastic group. Silk-RAD
substrate showed minimal proliferation. Silk decorated with RGD acts as a suitable
substrate for osteoblast integrins to attach. This result corresponds with a 2.5 fold
increase in ct5 (fibronectin integrin) and 2 fold increase in [31 expression on Silk-
RGD substrate at 24 hours. This data is supported by another study that shows a
gradual increase in fibronectin expression from day 1 to day 3 in neonatal mice
calvariae (46). Fibronectin expression has been shown to coincide with the
condensation of pre-osteoblasts prior to calcification and decreases once bone
mineralization commences (46).
Mineralization (calcium deposition) data in this study showed significant
difference between Silk and Plastic substrates with a p-value of 0.04. Comparison
of Silk-RGD and Silk-RAD with Plastic group showed significant differences with
p-values of <0.05. No statistically significant difference was seen for Silk-RGD
compared to Silk-RAD group with a p-value of 0.62. This is in contrast to another
study that showed a significant difference between Silk-RGD and Silk-RAD groups
at 2 and 4 weeks of culture (2). The main differences that might explain this
phenomenon are the cell population and the length of culture time. Our study used
primary human osteoblasts cultured for 5 weeks compared to the other study that
used Saos-2 osteoblasts-like cells cultured for 2 and 4 weeks. Another possible
explanation is an assumption that at 5 weeks primary human osteoblasts cultured
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on Silk-RAD are catching up with Silk-RGD group in mineral deposition. In any
case, further studies using primary human osteoblasts and Saos-2 osteoblast-like
cells cultured for the same length of time under similar conditions are warranted to
correctly explain this difference.
The ultimate therapeutic goal for tissue and bone loss due to periodontal
disease, trauma or metabolic bone disease is regeneration of tissues to a normal or
pre-disease state. Such regeneration requires differentiation of reparative cells and
production of appropriate amounts of extracellular matrix components in a precise
temporal and spatial manner to form specific types of soft and hard connective
tissues. This goal can be achieved with the guide of a biocompatible matrix
scaffold. A biomaterial scaffold with appropriate cell signaling molecules attached
can initiate this cellular differentiation and ultimately the repair.
Millions of Americans are afflicted with periodontal disease. It has been
estimated that at least 35% of the dentate U.S. adults aged 30 to 90 have
periodontitis, with 21.8% having a mild form and 12.6% having a moderate or
severe form (47). Periodontal disease causes destruction of supporting structures of
teeth namely alveolar bone, periodontal ligament and cementum. Periodontitis can
lead to loss of attachment, resorption of alveolar bone, destruction of connective
tissue matrix and cells and may lead to loss of teeth. Regeneration of damaged
periodontium especially alveolar bone can be achieved by the activity of local
progenitor cells found in paravascular locations of the periodontal ligament (PDL)
(48). However, a biomaterial scaffold is needed to provide a structure for the
progenitor cells to regenerate the damaged tissue, alveolar bone in this case.
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Bone regeneration techniques are also needed, particularly in the field of
oral and maxillofacial surgery. Trauma, including surgical removal of odontogenic
and non-odontogenic tumors in the oral and maxillofacial region causes bone
damage and injury that interferes with normal function and is often disfiguring.
Patients with congenital disorders may carry severe inherited bone and soft tissue
defects. It is estimated that over 300,000 procedures are performed in the US each
year to correct deformities specifically in the craniofacial region.
Silk has a long history of use as suture material and is FDA approved. It is
biocompatible, less immunogenic and inflammatory than collagens or polyesters
such as PLGA (1). Silk degrades and resorbs slowly and has minimal negative
impact on surrounding tissues. Silk exhibit strength, flexibility and resistance to
compression, properties that exceed all other known natural fibers and even rival
some synthetic high performance fibers. Silk fibroin in the form of 3D matrices
also exhibit mechanical properties that exceed commonly used polymeric
biomaterials such as calcium phosphate, even prior to efforts at optimization (1).
An ideal biomaterial should degrade slowly enough to maintain porosity for cell
ingrowth and new tissue formation. Silk achieve these outcomes without chemical
cross-linking, unlike collagens. Silk can be reprocessed into many different
biomaterial formats, including nano-diameter fibers via electro-spinning, hydrogels
and porous 3D matrices. An ideal biomaterial should be functionalizable with cell
growth factors. Silk cm be decorated with different biological factors to control
cell attachment and signaling because of the nature of their surface chemistry.
Specifically, silk can be decorated with RGD to improve cell attachment,
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proliferation and mineralization. Our data shows that decoration of silk with RGD
enhances proliferation of and mineralization by primary human osteoblasts. If 3D
silk scaffolds decorated with RGD are developed, these could have many dental
and maxillofacial applications such as treatment of bone loss due to periodontal
disease, jaw pathology, trauma and congenital defects. Before this goal could be
achieved, work needs to be done to study the signaling pathways and gene
expression mechanisms initiated by osteoblast integrin activation in response to
peptide decorated silk substrates.
TABLES
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Table 1
Comparison of mechanical properties of common silks (silkworm and spider
dragline) to several types of biomaterial fibers and tissues commonly used today
Altman, G. et al., 2003 (1)
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Materhl UTS (MPa. Mtulus (GPal % Strain at break
B, mor silk .(w/.ridn) )0 5----.I 2 19
1f,. mori si|k {w./o ridn)t’ 6|0..6)
B, mori si|k 740 0
Spider si|k’ 87 5---972 13 17-18
Collagen 0,9.... 7,.4 0,00t8...0,046 24....68
Co|k n X.linked 47...72 0,4-..-0, 8 12.... 16
PL* 28--.-50 1,2....3,0 2--:.,6
Tdon co.mprid of main.y co[Iagen) 150 1,5 12
Bone 160 20 3
.Kevlar (49 fir) 36 2, 7
Synthet Rub...r ) 0,00t 850
a. Bombyx mori silkworm silk determined from bave (multithread fibers naturally produced from the silk
worm coated in sericin).
b. Bombyx mori silkworm silk determined from single brins (individual fibroin filaments tbllowing extraction
of sericin).
c. Bombyx mori silkworm silk average calculated from data in Ref. (59).
d. Nephila clavipes silk produced naturally and through controlled silking.
e. Rat-tail collagen Type extruded fibers tested after stretching from 0% to 50%.
f. Rat-tail collagen dehydrothermally cross-linked and tested after stretching from 0% to 50%.
g. Polylactic acid with molecular weights ranging from 50,000 to 300,000.
31
Table 2
Ligand specificity of integrin receptors of human bone cells
Saito et al., 1949," (11)
32
Integrin receptor
(311
ECM protein
Laminin, Collagen
Laminin, Collagen
Fibronectin (RGD site)
Fibronectin
Fibronectin, Vitronectin, Fibrinogen, Thrombospondin,
von Willebrand factor, Osteopontin, Bone Sialoprotein
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Table 3
The sequence of plating human osteoblasts is shown for assaying proliferation at 72
hours of culture, for determining integrin expression at 24 hours and 7 days, and
measuring mineralization at 5 weeks of culture. Each plate consisted of six wells
and was plated at a density of 10,000 cells per cm. Surface area of each well was
9.6 cm. This experimental sequence was repeated three times.
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Plastic
Silk
Silk-RGD
Silk-RAD
Proliferation
Integrins
Mineralization
Proliferation
Integrins
Mineralization
Proliferation
Integrins
Mineralization
Proliferation
Integrins
Mineralization
0 time 24 hours
2 plates
2 plates
2 plates
2 plates
72 hours
1 plate
1 plate
1 plate
1 plate
07 days
2 plates
2 plates
2 plates
2 plates
35 days
1 plate
1 plate
1 plate
1 plate
FIGURES
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Figure 1
Proliferation of human osteoblast. Plastic, Silk, Silk-RGD and Silk-RAD
substrates at 72 hours of culture, determined by [3H]-thymidine incorporation
(DPM Disintegration Per Minute). No significant difference was found between
Plastic and Silk-RAD groups (p-value=0.355) and Plastic and Silk groups (p-
value=0.331). Significant differences were demonstrated between Plastic and Silk-
RGD groups at a p-value of 0.006 and between Silk-RGD and Silk-RAD groups at
p-value=0.002.
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Figure 2
Mineralization (calcium deposition) by human osteoblasts at 5-weeks. A
significant difference was found between Silk and Plastic substrates with a p-value
of 0.04, between Silk-RGD and Plastic and between Silk-RAD and Plastic with p-
values of <0.05. No statistically significant difference was seen for Silk-RGD
compared to Silk-RAD with a p-value of 0.62. Error bars are standard errors of the
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Figure 3
Western blots of integrin expression by human osteoblasts. At 0 time, 24 hours
and 7 days.
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Figure 4
Relative differences in integrin expression by human osteoblasts. Determined
by densitometric scans of the Western blots in Figure 3 at 24 hours compared to 0
time.
43
al a2 a5 aV 131 13
i24 P
ii24 S
i24 RGD
24 RAD
44
Figure 5
Relative differences in integrin expression in human osteoblast cultures. At 7
days compared to 24 hours of culture determined by densitometric scans of the
Western blot in Figure 3
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